Cargando…
The Frequency of Double Expresser in Selected Cases of High Grade Diffuse Large B-Cell Lymphomas
BACKGROUND: Diffuse large B-cell lymphomas (DLBCL) are fast-growing non-Hodgkin lymphomas that affect B-lymphocytes. Double expressor DLBCL is the concomitant expression of Myc and Bcl-2 proteins during lymphomas which results in poor prognosis of patients. This study aimed to determine the frequenc...
Autores principales: | Naseem, Maria, Asif, Muhammad, Khadim, Muhammad Tahir, Ud-Din, Hafeez, Jamal, Shahid, Shoaib, Iman |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
West Asia Organization for Cancer Prevention
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7445973/ https://www.ncbi.nlm.nih.gov/pubmed/32334477 http://dx.doi.org/10.31557/APJCP.2020.21.4.1103 |
Ejemplares similares
-
Next Generation Sequencing-Based Germline Panel Testing for Breast and Ovarian Cancers in Pakistan
por: Tariq, Hassan, et al.
Publicado: (2021) -
Stromal Expression of CD10 by Immunohistochemistry in Odontogenic Keratocyst (OKC), Dentigerous and Radicular Cysts and Its Correlation with Local Recurrence and Aggressive Behaviour
por: Ali, Anam, et al.
Publicado: (2019) -
Expression of Ki-67 and Βeta-Catenin in Pseudoepitheliomatous Hyperplasia and Squamous Cell Carcinoma in Oral Mucosal Biopsies : An Immunohistochemical Study
por: Ahmad, Bismah, et al.
Publicado: (2020) -
Outcomes of patients with double/triple expressor diffuse large B-cell lymphoma (DLBCL) treated with R-DA-EPOCH/R-CHOP: A single-center experience.
por: Devi, Kanta, et al.
Publicado: (2021) -
Advances in Polatuzumab Vedotin-PIIQ Therapy: A Review of Treatment Efficacy in Diffuse Large B Cell Lymphoma and High-Grade B Cell Lymphoma
por: Abdur Raqib, Moosa, et al.
Publicado: (2023)